The Nasdaq Composite Index has nearly doubled since the end of 2011, led by its riskiest sector: biotechnology.But biotech companies vary more than most in other industries. Some have no hopes of ever making money. And others are backed by products that are established in the marketplace and are quite profitable.The Nasdaq Biotechnology Index NBI, +0.40% has risen 227% since […]
You may have already been aware that the biotechnology sector has been hot over the past several years. But have you seen it lately? While most other sectors have been trending sideways, or even down as in the case of energy, the biotechnology sector has been absolutely on fire – with the largest biotech ETF iShares Nasdaq Biotechnology (NASDAQ: IBB) […]
Novavax (NVAX), in the biotechnology area, is one of the prettiest trend following biotech stocks at the moment.There have been multiple channel breakouts (trend following buy signal) over the months. A recent breakout was on January 9th. Both Darvas and Donchian indicated. It is up 45% since then.
Original article:
Trend following Novavax
See which stocks are being affected by Social Media
[…]
View gallery.Preface: The biotech stocks considered for this review were confined to those over $10 per share that traded at least 500K shares a day based on a 90-day average.For the longest time it seemed that for every new high the S&P 500 hit, biotech stocks, as measured by the iShares Nasdaq Biotechnology Index (NASDAQ: IBB), hit two new […]
Preface: The biotech stocks considered for this review were confined to those over $10 per share that traded at least 500K shares a day based on a 90-day average.For the longest time it seemed that for every new high the S&P 500 hit, biotech stocks, as measured by the iShares Nasdaq Biotechnology Index (NASDAQ: IBB), hit two new highs.Biotechnology […]
This post is an update to various past posts concerning the stock market bubble, most recently that of November 21, 2013 titled “Is The Stock Market Experiencing A Bubble?”Many people don’t believe that we are currently experiencing a stock market bubble because their primary reference regarding stock market bubbles is that of the mid- to late-1990s, in which there was […]
Some well-known biotechnology exchange traded funds could be stirred by Gilead Sciences (GILD) fourth-quarter earnings report released Tuesday after the close of U.S. markets.The California-based company posted net income of $3.49 billion, or $2.18 a share, compared with $791 million, or 47 cents a share, a year earlier as revenue more than doubled to $7.31 billion from $3.12 billion on […]
Never mind how the U.S. stock market is posting modest year-to-date losses close to 2%. Momentum stocks are up and so is risk taking.A comparison of the iShares MSCI USA Momentum Factor ETF (MTUM) – a good proxy for the risk appetite of bullishly trending stocks – versus the S&P 500 (^GSPC) shows that momentum stocks have not yet lost their luster. Over the past […]
SummaryBiotech stocks should outperform the market in 2015. However the biotech sector is linked to healthcare fundamentals like government pricing policy.
The industry is better financed than any time in its history driving innovation and new product growth. The appetite for M&A and IPOs will continue.
Biopharmaceutical stocks defy traditional analysis and have been a safe haven from global economic news.
2015: Another […]
Over the last several years, there has rarely been a bad time to own biotechnology exchange traded funds. That much is confirmed by the presence of multiple biotech ETFs on the annual lists of the top 10 sector funds.In 2014, each of the five major biotech ETFs ranked among the year’s top 10 sector ETFs. That includes the First Trust […]
